5-Iodo-indirubin-3'-monoxime |
カタログ番号GC35162 |
5-ヨード-インジルビン-3'-モノキシムは強力な GSK-3β、CDK5/P25、および CDK1/サイクリン B 阻害剤であり、キナーゼの触媒部位への結合について ATP と競合し、IC50 は 9、20、および 25 nM です。それぞれ。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 331467-03-9
Sample solution is provided at 25 µL, 10mM.
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase, with IC50s of 9, 20 and 25 nM, respectively[1]. GSK-3β|9 nM (IC50)|Cdk5/p25|20 nM (IC50)|Cdk1/cyclin B|25 nM (IC50)
[1]. Leclerc S, et al. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors• J Biol Chem. 2001 Jan 5;276(1):251-60.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *